Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Foeldvari

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Autoimmunity Reviews|September 15, 2019
Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern"Vanessa Smith, Amber Vanhaecke, Ariane L Herrick, et al.
Annals of the Rheumatic Diseases|March 19, 2010
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extensionNicolino Ruperto, Daniel J Lovell, Ruben Cuttica, et al.
Arthritis Care & Research|November 14, 2025
Sarilumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Dose-Finding and One-Year Analysis of a Phase 2b, Open-Label, Multicenter StudyFabrizio De Benedetti, Inmaculada C Penadés, Irina Nikishina, et al.
AMRC Open Research|May 6, 2024
Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised SclerodermaYasin Desai, Thomas Jaki, Michael W Beresford, et al.
Expert Review of Clinical Immunology|December 27, 2023
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022Ivan Foeldvari, Kathryn S Torok, Jordi Antón, et al.
The British Journal of Ophthalmology|April 4, 2024
A practical approach to uveitis screening in children with juvenile idiopathic arthritisIvan Foeldvari, Marcela Bohn, Harry Petrushkin, et al.
Expert Review of Clinical Immunology|March 8, 2025
Guidance for stem cell therapy for juvenile systemic sclerosis patientsIvan Foeldvari, Kathryn S Torok, Juliana Silva, et al.
Pediatric Rheumatology Online Journal|January 24, 2018
Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in GermanyClaas H Hinze, Dirk Holzinger, Elke Lainka, et al.
Arthritis and Rheumatism|February 5, 2005
A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety resultsNicolino Ruperto, Irina Nikishina, Evgueni D Pachanov, et al.
Pediatric Rheumatology Online Journal|March 21, 2024
Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort studyFlorian Milatz, Sandra Hansmann, Jens Klotsche, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Autoimmunity Reviews|September 15, 2019
Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern"Vanessa Smith, Amber Vanhaecke, Ariane L Herrick, et al.
Annals of the Rheumatic Diseases|March 19, 2010
Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extensionNicolino Ruperto, Daniel J Lovell, Ruben Cuttica, et al.
Arthritis Care & Research|November 14, 2025
Sarilumab in Polyarticular-Course Juvenile Idiopathic Arthritis: Dose-Finding and One-Year Analysis of a Phase 2b, Open-Label, Multicenter StudyFabrizio De Benedetti, Inmaculada C Penadés, Irina Nikishina, et al.
AMRC Open Research|May 6, 2024
Prior elicitation of the efficacy and tolerability of Methotrexate and Mycophenolate Mofetil in Juvenile Localised SclerodermaYasin Desai, Thomas Jaki, Michael W Beresford, et al.
Expert Review of Clinical Immunology|December 27, 2023
Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022Ivan Foeldvari, Kathryn S Torok, Jordi Antón, et al.
The British Journal of Ophthalmology|April 4, 2024
A practical approach to uveitis screening in children with juvenile idiopathic arthritisIvan Foeldvari, Marcela Bohn, Harry Petrushkin, et al.
Expert Review of Clinical Immunology|March 8, 2025
Guidance for stem cell therapy for juvenile systemic sclerosis patientsIvan Foeldvari, Kathryn S Torok, Juliana Silva, et al.
Pediatric Rheumatology Online Journal|January 24, 2018
Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in GermanyClaas H Hinze, Dirk Holzinger, Elke Lainka, et al.
Arthritis and Rheumatism|February 5, 2005
A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety resultsNicolino Ruperto, Irina Nikishina, Evgueni D Pachanov, et al.
Pediatric Rheumatology Online Journal|March 21, 2024
Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort studyFlorian Milatz, Sandra Hansmann, Jens Klotsche, et al.
Pageof 18